Linkedin Facebook X-twitter
From Data to Discovery Uniting Africa Against Amyloidosis

My Account

LOG IN
open-navigation
close-navigation
Login / Signup

Category Amyloidosis Treatment

27 Aug

Device Therapy in Cardiac Amyloidosis: Pacemakers, ICDs and Cardiac Resynchronization Therapy

Learn how pacemakers, ICDs and cardiac resynchronization therapy (CRT) are used in cardiac amyloidosis, including their indications, potential benefits, limitations and the importance of individualized patient selection.

READ MORE

26 Aug

Liver Transplantation in Amyloidosis: When Is It Considered?

Liver transplantation was historically an important disease-modifying treatment for hereditary ATTR amyloidosis. Learn which patients may still be considered today, how genotype and cardiac involvement affect eligibility, why disease can progress after transplantation, and how modern TTR-directed therapies have changed its role.

READ MORE

25 Aug

Kidney Transplantation in Amyloidosis: Who Is a Canddidate?

Kidney transplantation can offer selected patients with amyloidosis-related kidney failure long-term dialysis independence. Learn how amyloid type, disease control, cardiac involvement and recurrence risk influence transplant eligibility and outcomes.

READ MORE

25 Aug

Heart Transplantation in Cardiac Amyloidosis: Patient Selection, Eligibility and Outcomes

Heart transplantation can be an important treatment option for carefully selected patients with advanced cardiac amyloidosis. Learn how transplant teams assess eligibility, the differences between AL and ATTR amyloidosis, extracardiac disease, combined-organ transplantation and modern transplant outcomes.

READ MORE

25 Aug

Organ Transplantation in Amyloidosis: When Is It Considered?

Organ transplantation can be an important treatment option for carefully selected patients with amyloidosis and advanced organ dysfunction. This article explains when heart, kidney, liver, or combined transplantation may be considered in AL, ATTR, and AA amyloidosis, and why disease control and multidisciplinary assessment are essential.

READ MORE

15 Aug

Cardiac Amyloidosis Treatment: ATTR, AL and Heart Failure Management

Cardiac amyloidosis treatment depends on the amyloid type. This guide explains current ATTR and AL therapies, including TTR stabilizers, TTR silencers, plasma-cell-directed treatment, diuretics, anticoagulation and multidisciplinary heart failure care.

READ MORE